IBC's Sixth AnnualSingle-Use Applications for Biopharmaceutical Manufacturing

IBC’s Single-Use Applications for Biopharmaceutical Manufacturing conference is well known in the industry as the largest, most well-respected event focused solely on disposables. This year’s program provides a thorough education on topics such as equipment technologies, and processes through validation; integrating disposables into facilities; implementation tools; and new data from vendors on how plastics are manufactured. Our faculty of experts will present their most up-to-date knowledge and proven strategies you can implement at your company to ensure it is maximizing its single-use systems and moving them forward.

See how to minimize investment and get your drug candidates into production faster. Hear the latest case studies for several types of biologic products being produced using disposables. Benchmark your company’s efforts by hearing reports from all types of companies including Amgen, Genentech, Bayer HealthCare, Wyeth, Pfizer, Sanofi Pasteur, BristolMyers Squibb, Novavax, Acceleron, OncoMed, National Serum Institute of Denmark, Crucell, Shire, and more.

Register now to ensure that your company is on the cutting edge of this important time- and cost-saving trend. Be sure to sign up for the workshop on extractables and leachables analysis to ensure the quality and safety of your company’s products

New/Hot This Year

Technology Idol: Conceptually based on popular television programs such as “American Idol” and the United Kingdom’s “Pop Idol,” this session presents the latest technologies from manufacturers of single-use equipment or systems including application data when possible. After each 10-minute presentation, a panel of end-users will question the developers for five minutes about application concerns.

Audience Interactive Panel Discussion: Part one looks at open-platform approaches for designing and implementing fully disposable process trains. Part two focuses on the continuing challenge of interchangeability.

PMBPSA’s Second Annual Business Roundtable: The topic will be assisting end users in adopting and adapting disposables in their manufacturing processes. This business roundtable is for both end users and suppliers of single-use systems.

Keynotes

Evolution of Single-Use Applications in Biomanufacturing — Past, Present, and Future: Eric John Bergin (business development manager for Charter Medical Ltd.) offers an exploration into the genesis of disposables in biomanufacturing and some of the early innovations that created the foundation from which today’s single-use technologies came. He will briefly overview the range of applications into which those have evolved and discuss optimizing partnerships between biomanufacturers and suppliers on future innovations.

The Game Changer — Transforming Biopharmaceutical Landscape through Applications of Single-Use Technologies: Ran Zheng (executive director and plant manager of clinical operations at Amgen Inc.) discusses how the application of single-use technologies is coming of age and joining other driving forces to reshape the landscape of the biopharmaceutical industry. These innovations will create new platforms for bioprocessing to offer competitive advantages and tremendous opportunities to current biomanufacturers. Moreover, the increasing acceptance of single-use systems with proven success will help enable niche products and bring emergent players to the marketplace.

Featured Presentation

The Future of Biologics Manufacturing: Timothy Matthews (senior engineer and group leader of process development engineering at Genentech, Inc.) says that several technologies have recently been developed and investigated at Genentech and other companies that can potentially revolutionize the way manufacturing facilities are built and processes are performed. Portable cleanroom technology, the use of cell culture perfusion for antibody production, sequential multicolumn chromatography, and in-line dilution of buffer concentrates may allow for significantly less expensive and more modular facilities of sufficient capacity to match production needs just in time.